Authors
Loading...
Narrative review observes dopamine receptor 3's impact on schizophrenia, bipolar disorder, and more, suggesting avenues for targeted treatment.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: